Local anaesthetics. Local anaesthetics
Conditions
Interventions
Treatment - Drugs
Intervention 1: groupB: supraclavicular injection of 25 ml of bupivacaine 0.5% and of propofol 50 mcg / kg / min intravenously. Intervention 2: groupA: supraclavicular injection of 25 ml of bupivacai
groupB: supraclavicular injection of 25 ml of bupivacaine 0.5% and of propofol 50 mcg / kg / min intravenously.
groupA: supraclavicular injection of 25 ml of bupivacaine and 0.5 mg / kg / min of dexamethmonide intravenously
Sponsors
Tehran University Of Medical Sciences Vice Chancellor Of Research
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 20-50 years old; ASA class III, II, I; BMI less than 35; no history of drug allergy; satisfaction of the patient and filling out the consent form. Exclusion criteria: failure to perform supraclavicular block; duration of surgery for more than 180 minutes; cancellation of operation; occurrence of surgical complication during surgery; the need for general anesthesia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensory block onset. Timepoint: sensory block will be checked continuously after completion of injection until complete sensory and motor block. Method of measurement: pinprick test and a verbal rating scale from 100% (normal sensation) to 0 (no sensation).;Sensory block duration. Timepoint: after complete sensory block and every 15 minutes following the end of operation. Method of measurement: pinprick test and a verbal rating scale from 100% (normal sensation) to 0 (no sensation).;Motor block onset. Timepoint: motor block will be checked continuously after completion of injection until complete motor block. Method of measurement: Lovett rating scale.;Motor block duration. Timepoint: after complete motor block and every 15 minutes following the end of operation. Method of measurement: the Lovett rating scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: continuously monitoring while the surgery is performing. Method of measurement: manometer.;Diastolic blood pressure. Timepoint: continuously monitoring while the surgery is performing. Method of measurement: manometer.;Heart rate. Timepoint: continuously monitoring while the surgery is performing. Method of measurement: Monitoring.;Respiratory depression. Timepoint: continuously monitoring while the surgery is performing. Method of measurement: O2 saturation & Respiratory Rate.;Drug consumption in the 24 hours after surgery. Timepoint: patient need. Method of measurement: Medical records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Fatemeh Elmi
Shariati Hospital, Anesthesilogy Department
Outcome results
None listed